Vivaldi Coelho Rogerio
SEC insider (Form 3/4/5 filer). CIK 0001610381. Director at Crinetics Pharmaceuticals, Inc. (CRNX) and 1 other issuer. 13 reported Form 4/5 transactions since Sep 2024; latest on Sep 1, 2026. Located in SAN DIEGO, CA.
Companies Vivaldi Coelho Rogerio has filed insider reports for
- Crinetics Pharmaceuticals, Inc. (CRNX): Director
- Viatris Inc (VTRS): Director
Vivaldi Coelho Rogerio
CIK: 0001610381
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
DispositionDirect5.9K shares at avg. $85.00$504K - Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
DispositionDirect13.3K shares at avg. $85.00$1.1M - Jul 2, 2026CRNX
Crinetics Pharmaceuticals, Inc.
SaleDirect3K shares at avg. $40.00$120K - Jun 18, 2026CRNX
Crinetics Pharmaceuticals, Inc.
AwardDirect5.9K shares- - Mar 12, 2026CRNX
Crinetics Pharmaceuticals, Inc.
SaleDirect4.5K shares at avg. $36.08$162K - Mar 12, 2026CRNX
Crinetics Pharmaceuticals, Inc.
SaleDirect523 shares at avg. $36.77$19K - Mar 6, 2026VTRS
Viatris Inc
ExerciseDirect23.7K shares- - Mar 6, 2026VTRS
Viatris Inc
AwardDirectRestricted Stock Units
15.9K shares- - Mar 6, 2026VTRS
Viatris Inc
ExerciseDirect1.2K shares- - Jun 11, 2025CRNX
Crinetics Pharmaceuticals, Inc.
AwardDirect6.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 1, 2026 |  CRNX Crinetics Pharmaceuticals, Inc. | Disposition | 5,925 | $85.00 | $503,625 | Direct |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Disposition | 13,300 | $85.00 | $1,130,500 | Direct |
| Jul 2, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Sale | 3,000 | $40.00 | $120,000 | Direct |
| Jun 18, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Award | 5,925 | - | $0 | Direct |
| Mar 12, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Sale | 4,477 | $36.08 | $161,530 | Direct |
| Mar 12, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Sale | 523 | $36.77 | $19,231 | Direct |
| Mar 6, 2026 |  VTRS Viatris Inc | Exercise | 23,660 | - | $0 | Direct |
| Mar 6, 2026 | VTRS Viatris Inc | Award Restricted Stock Units | 15,890 | - | - | Direct |
| Mar 6, 2026 | VTRS Viatris Inc | Exercise | 1,175 | - | $0 | Direct |
| Jun 11, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Award | 6,900 | - | - | Direct |
1-10 of 13 transactions